Literature DB >> 18486995

Synthesis, pharmacological screening, quantum chemical and in vitro permeability studies of N-Mannich bases of benzimidazoles through bovine cornea.

E Philip Jesudason1, S K Sridhar, E J Padma Malar, P Shanmugapandiyan, Mohammed Inayathullah, V Arul, D Selvaraj, R Jayakumar.   

Abstract

A novel series of N-Mannich bases of benzimidazole derivatives were synthesized and characterized by (1)H NMR, IR spectral studies and elemental analysis. The compounds were screened for analgesic and anti-inflammatory activity. 1-((Diethylamino)-methyl)-2-styryl benzimidazole 4 at 40mg/kg was found to be equipotent to paracetamol. 1-((Piperidin-1-yl) methyl)-2-styryl-benzimidazole 6 at 40mg/kg was found to be more potent than Diclofenac. Corneal permeability and quantum chemical calculations were performed to correlate the hydrogen bonding ability with permeability and activity. The energies of the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) were correlated with pharmacological activity. The semi-empirical PM3 calculations (quantum chemical calculations) revealed that E(LUMO) and energy gap DeltaE were capable of accounting for the high in vitro bovine corneal permeability and activity of the compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486995     DOI: 10.1016/j.ejmech.2008.03.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

Review 1.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

2.  Synthesis, density functional theory study and in vitro antimicrobial evaluation of new benzimidazole Mannich bases.

Authors:  Maria Marinescu; Ludmila Otilia Cinteză; George Iuliu Marton; Mariana-Carmen Chifiriuc; Marcela Popa; Ioana Stănculescu; Christina-Marie Zălaru; Cristina-Elena Stavarache
Journal:  BMC Chem       Date:  2020-07-25

3.  Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors.

Authors:  Nafiz Öncü Can; Ulviye Acar Çevik; Begüm Nurpelin Sağlık; Yusuf Özkay; Özlem Atlı; Merve Baysal; Ümide Demir Özkay; Özgür Devrim Can
Journal:  Molecules       Date:  2017-08-19       Impact factor: 4.411

Review 4.  Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review.

Authors:  Sumit Tahlan; Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  BMC Chem       Date:  2019-08-06

5.  Synthesis, characterization and theoretical determination of corrosion inhibitor activities of some new 4,5-dihydro-1H-1,2,4-Triazol-5-one derivatives.

Authors:  Murat Beytur; Zeynep Turhan Irak; Sevda Manap; Haydar Yüksek
Journal:  Heliyon       Date:  2019-06-04

6.  Design, synthesis and biological profile of heterocyclic benzimidazole analogues as prospective antimicrobial and antiproliferative agents.

Authors:  Sumit Tahlan; Sanjiv Kumar; Kalavathy Ramasamy; Siong Meng Lim; Syed Adnan Ali Shah; Vasudevan Mani; Ranjana Pathania; Balasubramanian Narasimhan
Journal:  BMC Chem       Date:  2019-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.